Tocilizumab modulates serum levels of adiponectin and chemerin in patients with rheumatoid arthritis: potential cardiovascular protective role of IL-6 inhibition. - Concepedia

Concepedia

Publication | Closed Access

Tocilizumab modulates serum levels of adiponectin and chemerin in patients with rheumatoid arthritis: potential cardiovascular protective role of IL-6 inhibition.

39

Citations

0

References

2019

Year

Antonella Fioravanti, Sara Tenti, Arianna Damiani, Li Gobbi F, Francesca Bandinelli, Sara Cheleschi, M. Galeazzi, Maurizio Benucci

Abstract

TCZ is able to regulate serum levels of chemerin and adiponectin in RA patients, independently of the disease treatment response, which contributes to explain the CV safety of TCZ.